乌鸦传媒

Charles Bankhead

Charles Bankhead

Authors >

Charles Bankhead

Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. His career spans more than 30 years, including a decade with Medical World News, a leading medical trade magazine of its time. He had a long and successful freelance career before joining 乌鸦传媒 in 2007. Charles graduated with honors from Texas Tech University, receiving a BA in journalism, and completed a master's degree in mass communication, with specialization in health communication, also at Texas Tech.

Connect:

email image

Latest from Charles Bankhead

<乌鸦传媒>ED Visits for Air, Paintball Gun Injuries Fall

Injuries caused by air and paintball guns have declined in recent years but still account for more than 20,000 emergency department visits annually, according to a government study.

<乌鸦传媒>ASCO: Targeted Agent Slows Recurrent Ovarian Cancer

CHICAGO -- Women with recurrent platinum-sensitive ovarian cancer had a 50% improvement in progression-free survival when bevacizumab (Avastin) was added to chemotherapy, results of a multicenter randomized trial showed.

<乌鸦传媒>15 Eggs Magic Number for Best Results in IVF

The odds of achieving a live birth after in vitro fertilization (IVF) increased steadily with the number of eggs retrieved after ovarian stimulation, topping out at about 15, data from a large IVF registry showed.

<乌鸦传媒>SID: No Skin Cancer Risk Seen With Prednisone

PHOENIX -- Use of systemic corticosteroids did not increase the risk of nonmelanoma skin cancer in a prospective study, contradicting previous evidence from several retrospective studies, investigators reported here.

<乌鸦传媒>Poor IUD Positioning Linked to Pregnancies

Missing or improperly positioned intrauterine devices might have contributed to half of unintended pregnancies in a group of women who were using the devices, data from a small retrospective study suggests.

<乌鸦传媒>ASCO GU: Switch to Degarelix Slows PSA

ORLANDO -- PSA progression slowed significantly in prostate cancer patients switched to degarelix (Firmagon) after 12 months of leuprolide therapy, data from an open-label extension study showed.

<乌鸦传媒>ASCO GU: Rise in PSA Slowed by Pomegranate

ORLANDO -- Prostate cancer patients had a six-month gain in PSA doubling time when treated with pomegranate extract, according to data reported here.

<乌鸦传媒>ASCO GU: Long Learning Curve for Robotic Prostate Removal

ORLANDO -- Three experienced surgeons needed more than 1,600 cases to achieve acceptable outcomes with robotic-assisted laparoscopic prostatectomy, data from a retrospective chart review showed.

<乌鸦传媒>You Wouldn't Understand . . . It's a Hat Thing

<乌鸦传媒>ASCO Breast: Gamma Imaging Tops Breast Ultrasound

NATIONAL HARBOR, Md. -- Breast-specific gamma imaging (BSGI) outperformed breast ultrasound for evaluating patients with indeterminate mammograms in a retrospective comparison of the two imaging techniques, researchers reported here.

鈥�

109